<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The standard for the pathological identification of B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is the World Health Organization (WHO) classification, which integrates <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0000002'>morphology</z:mp>, immunophenotype, recurrent genetic abnormalities and clinical features </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphoma</z:hpo> entities defined in this classification are derived from virtually every stage of <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell differentiation </plain></SENT>
<SENT sid="2" pm="."><plain>This classification which has gained wide acceptance has proven useful in patient management and treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Novel findings based on gene expression profiling have however started to reveal that not <z:hpo ids='HP_0000001'>all</z:hpo> described entities are entirely molecularly homogeneous </plain></SENT>
<SENT sid="4" pm="."><plain>This report describes distinct examples of the more common B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> along with the pathogenetic models and gives some information on the novel gene expression profiling data </plain></SENT>
</text></document>